SRPT Q1 2026 Earnings EPS Surges 18467 Above Estimates Amid Strong Gene Therapy Progress CMP Q1 2026 Earnings EPS Beats Estimates Shares Rise 25 OXLCN Q4 2025 Earnings EPS Misses Estimates but Stock Edges Higher ACTU Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Stage JSPR Q1 2026 Earnings Stunning EPS Beat Highlights Cost Discipline as PreRevenue Biotech Advances Pipeline QRHC Q1 2026 Earnings EPS Misses Estimates Stock Gains Despite Loss